PURSOL ACTIVE

Primær information

  • Handelsnavn:
  • PURSOL ACTIVE (EURO-RANGE)
  • Brugt til:
  • Mennesker
  • Medicin typen:
  • Medicinsk udstyr

Dokumenter

  • for den brede offentlighed:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for offentligheden.

  • for sundhedspersonale:
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.


    Anmode informationsbrochure for sundhedspersonale.

Lokation

  • Fås i:
  • PURSOL ACTIVE (EURO-RANGE)
    Danmark
  • Sprog:
  • dansk

Andre oplysninger

Status

  • Kilde:
  • Ecolab
  • Autorisationsnummer:
  • 108426E
  • Sidste ændring:
  • 12-03-2018
  • Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.

    Anmode informationsbrochure for offentligheden.



  • Dokumenter på andre sprog er tilgængelige her

17-4-2018

Epic Products, LLC, Issues Voluntary Nationwide Recall of All Lots of Euphoric Capsules Due to Presence of Undeclared Sildenafil and Tadalafil

Epic Products, LLC, Issues Voluntary Nationwide Recall of All Lots of Euphoric Capsules Due to Presence of Undeclared Sildenafil and Tadalafil

Overland Park, KS, Epic Products, LLC is voluntarily recalling all lots of Euphoric capsules, packaged in 1 count blister cards, 3 count bottles, and 12 count bottles to the consumer level. FDA analysis found samples of Euphoric to be tainted with undeclared sildenafil and tadalafil, active ingredients in two FDA-approved prescription drug products, also known as phosphodiesterase 5-inhibitors (PDE-5 inhibitors), used to treat male erectile dysfunction (ED). The presence of sildenafil and tadalafil in E...

FDA - U.S. Food and Drug Administration

16-4-2018

Women taking birth control pills reminded to return any packages for replacement if the pills are missing or look unusual

Women taking birth control pills reminded to return any packages for replacement if the pills are missing or look unusual

In light of continuing complaints of quality issues involving certain prescription birth control pills, Health Canada is reminding women to check their packages of birth control pills. If you notice anything unusual in the package, such as missing or damaged pills, you should return the package to the pharmacy for replacement as soon as possible. Skipping a dose because the pill is missing, or taking a damaged (for example, chipped or fragmented) pill, may increase the risk of pregnancy because less acti...

Health Canada

14-4-2018

'Rhino 69 Extreme 50000' Recalled due to Presence of Active Ingredient 'Tadalafil'

'Rhino 69 Extreme 50000' Recalled due to Presence of Active Ingredient 'Tadalafil'

AMA Wholesale Inc. (Distributor/Re-seller), is voluntarily recalling Rhino 69 Extreme 50000 capsules to the consumer level. FDA analysis found the product to be tainted with undeclared tadalafil. Tadalafil is an active ingredient in a FDA-approved prescription drug that is used for erectile dysfunction.

FDA - U.S. Food and Drug Administration

10-7-2018

Raloxifene Teva (Teva B.V.)

Raloxifene Teva (Teva B.V.)

Raloxifene Teva (Active substance: Raloxifene hydrochloride) - Centralised - Yearly update - Commission Decision (2017)4939 of Tue, 10 Jul 2018

Europe -DG Health and Food Safety

23-4-2018

Volibris (Glaxo Group Ltd)

Volibris (Glaxo Group Ltd)

Volibris (Active substance: Ambrisentan) - Centralised - Yearly update - Commission Decision (2018)2514 of Mon, 23 Apr 2018

Europe -DG Health and Food Safety

23-4-2018

Sutent (Pfizer Limited)

Sutent (Pfizer Limited)

Sutent (Active substance: sunitinib) - Centralised - Yearly update - Commission Decision (2018)2512 of Mon, 23 Apr 2018

Europe -DG Health and Food Safety

23-4-2018

Deltyba (Otsuka Novel Products GmbH)

Deltyba (Otsuka Novel Products GmbH)

Deltyba (Active substance: delamanid) - Centralised - Annual renewal - Commission Decision (2018)2492 of Mon, 23 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2552/R/27

Europe -DG Health and Food Safety

23-4-2018

Xadago (Zambon S.p.A.)

Xadago (Zambon S.p.A.)

Xadago (Active substance: safinamide) - Centralised - Yearly update - Commission Decision (2018)2513 of Mon, 23 Apr 2018

Europe -DG Health and Food Safety

18-4-2018

EU/3/18/2007 (Dr Philippe Moullier)

EU/3/18/2007 (Dr Philippe Moullier)

EU/3/18/2007 (Active substance: Adeno-associated viral vector serotype 8 containing the human acid alpha-glucosidase gene) - Orphan designation - Commission Decision (2018)2403 of Wed, 18 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/255/17

Europe -DG Health and Food Safety

18-4-2018

EU/3/18/2013 (Roche Registration Limited)

EU/3/18/2013 (Roche Registration Limited)

EU/3/18/2013 (Active substance: Polatuzumab vedotin) - Orphan designation - Commission Decision (2018)2409 of Wed, 18 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/231/17

Europe -DG Health and Food Safety

18-4-2018

EU/3/18/2012 (IDEA Innovative Drug European Associates Limited)

EU/3/18/2012 (IDEA Innovative Drug European Associates Limited)

EU/3/18/2012 (Active substance: Genetically modified replication-incompetent herpes simplex virus-1 expressing collagen VII) - Orphan designation - Commission Decision (2018)2408 of Wed, 18 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/244/17

Europe -DG Health and Food Safety

18-4-2018

EU/3/18/2011 (Ultragenyx Germany GmbH)

EU/3/18/2011 (Ultragenyx Germany GmbH)

EU/3/18/2011 (Active substance: Burosumab) - Orphan designation - Commission Decision (2018)2407 of Wed, 18 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/026/17

Europe -DG Health and Food Safety

18-4-2018

EU/3/18/2010 (Novartis Europharm Limited)

EU/3/18/2010 (Novartis Europharm Limited)

EU/3/18/2010 (Active substance: Branaplam) - Orphan designation - Commission Decision (2018)2406 of Wed, 18 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/249/17

Europe -DG Health and Food Safety

18-4-2018

EU/3/18/2009 (SOTIO a.s)

EU/3/18/2009 (SOTIO a.s)

EU/3/18/2009 (Active substance: Autologous dendritic cells pulsed with killed ovarian cancer cells and matured by TLR3 ligand ex vivo) - Orphan designation - Commission Decision (2018)2405 of Wed, 18 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/246/17

Europe -DG Health and Food Safety

18-4-2018

EU/3/18/2008 (StolmAr and Partner PatentanwAlte PartG mbB)

EU/3/18/2008 (StolmAr and Partner PatentanwAlte PartG mbB)

EU/3/18/2008 (Active substance: Adeno-associated viral vector serotype 9 encoding miRNA against human superoxide dismutase 1) - Orphan designation - Commission Decision (2018)2404 of Wed, 18 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/254/17

Europe -DG Health and Food Safety

18-4-2018

Melatonin (haemorrhage) (Therapicon Srl)

Melatonin (haemorrhage) (Therapicon Srl)

Melatonin (haemorrhage) (Active substance: Melatonin) - Refusal of orphan designation - Commission Decision (2018)2410 of Wed, 18 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/127/17

Europe -DG Health and Food Safety

18-4-2018

Equilis West Nile (Intervet International B.V.)

Equilis West Nile (Intervet International B.V.)

Equilis West Nile (Active substance: Inactivated chimeric flavivirus strain YF-WN) - Centralised - Renewal - Commission Decision (2018)2390 of Wed, 18 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/V/2241/R/5

Europe -DG Health and Food Safety

18-4-2018

BTVPUR (Merial)

BTVPUR (Merial)

BTVPUR (Active substance: Bluetongue disease virus vaccine (containing either serotypes 1, 4 or 8) (inactivated)) - Centralised - Yearly update - Commission Decision (2018)2391 of Wed, 18 Apr 2018

Europe -DG Health and Food Safety

17-4-2018

Sialanar (Proveca Limited)

Sialanar (Proveca Limited)

Sialanar (Active substance: glycopyrronium bromide) - Centralised - Yearly update - Commission Decision (2018)2340 of Tue, 17 Apr 2018

Europe -DG Health and Food Safety

17-4-2018

EU/3/11/945 (Mallinckrodt Pharmaceuticals Ireland Limited)

EU/3/11/945 (Mallinckrodt Pharmaceuticals Ireland Limited)

EU/3/11/945 (Active substance: Ornithine phenylacetate) - Transfer of orphan designation - Commission Decision (2018)2355 of Tue, 17 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/105/11/T/03

Europe -DG Health and Food Safety

17-4-2018

PritorPlus (Bayer AG)

PritorPlus (Bayer AG)

PritorPlus (Active substance: Telmisartan / hydrochlorothiazide) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2342 of Tue, 17 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/414/T/115

Europe -DG Health and Food Safety

17-4-2018

Pritor (Bayer AG)

Pritor (Bayer AG)

Pritor (Active substance: telmisartan) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2344 of Tue, 17 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/210/T/124

Europe -DG Health and Food Safety

17-4-2018

Autologous skeletal myoblasts expanded ex vivo (Assistance Publique - Hopitaux de Paris (APHP))

Autologous skeletal myoblasts expanded ex vivo (Assistance Publique - Hopitaux de Paris (APHP))

Autologous skeletal myoblasts expanded ex vivo (Active substance: Autologous skeletal myoblasts expanded ex vivo) - Refusal of orphan designation - Commission Decision (2018)2354 of Tue, 17 Apr 2018 European Medicines Agency (EMA) procedure number: EMA/OD/144/17

Europe -DG Health and Food Safety

17-4-2018

Clevor (Orion Corporation)

Clevor (Orion Corporation)

Clevor (Active substance: Ropinirole) - Centralised - Authorisation - Commission Decision (2018)2338 of Tue, 17 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/V/C/4417

Europe -DG Health and Food Safety

17-4-2018

Bretaris Genuair (AstraZeneca AB)

Bretaris Genuair (AstraZeneca AB)

Bretaris Genuair (Active substance: aclidinium bromide) - Centralised - Yearly update - Commission Decision (2018)2345 of Tue, 17 Apr 2018

Europe -DG Health and Food Safety

17-4-2018

Alpivab (BioCryst UK Ltd.)

Alpivab (BioCryst UK Ltd.)

Alpivab (Active substance: peramivir) - New authorisation - Commission Decision (2018)2370 of Tue, 17 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4299

Europe -DG Health and Food Safety

17-4-2018

Eklira Genuair (AstraZeneca AB)

Eklira Genuair (AstraZeneca AB)

Eklira Genuair (Active substance: aclidinium bromide) - Centralised - Yearly update - Commission Decision (2018)2347 of Tue, 17 Apr 2018

Europe -DG Health and Food Safety

17-4-2018

Equip WNV (Zoetis Belgium S.A.)

Equip WNV (Zoetis Belgium S.A.)

Equip WNV (Active substance: West Nile fever vaccine (inactivated recombinant)) - Centralised - Yearly update - Commission Decision (2018)2339 of Tue, 17 Apr 2018

Europe -DG Health and Food Safety

17-4-2018

Memantine ratiopharm (ratiopharm GmbH)

Memantine ratiopharm (ratiopharm GmbH)

Memantine ratiopharm (Active substance: memantine) - Centralised - Renewal - Commission Decision (2018)2369 of Tue, 17 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2671/R/11

Europe -DG Health and Food Safety

16-4-2018

Kinzalkomb (Bayer AG)

Kinzalkomb (Bayer AG)

Kinzalkomb (Active substance: Telmisartan / hydrochlorothiazide) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2294 of Mon, 16 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/415/T/105

Europe -DG Health and Food Safety

16-4-2018

Lumigan (Allergan Pharmaceuticals Ireland)

Lumigan (Allergan Pharmaceuticals Ireland)

Lumigan (Active substance: Bimatoprost) - Centralised - Yearly update - Commission Decision (2018)2300 of Mon, 16 Apr 2018

Europe -DG Health and Food Safety

16-4-2018

Ravicti (Horizon Pharma Ireland Limited)

Ravicti (Horizon Pharma Ireland Limited)

Ravicti (Active substance: Glycerol phenylbutyrate) - Centralised - Yearly update - Commission Decision (2018)2302 of Mon, 16 Apr 2018

Europe -DG Health and Food Safety

16-4-2018

Actrapid (Novo Nordisk A/S)

Actrapid (Novo Nordisk A/S)

Actrapid (Active substance: Insulin human (rDNA)) - Centralised - Yearly update - Commission Decision (2018)2301 of Mon, 16 Apr 2018

Europe -DG Health and Food Safety

16-4-2018

Vidaza (Celgene Europe Limited)

Vidaza (Celgene Europe Limited)

Vidaza (Active substance: Azacitidine) - Centralised - Yearly update - Commission Decision (2018)2305 of Mon, 16 Apr 2018

Europe -DG Health and Food Safety

16-4-2018

Signifor (Novartis Europharm Limited)

Signifor (Novartis Europharm Limited)

Signifor (Active substance: pasireotide) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2304 of Mon, 16 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2052/T/37

Europe -DG Health and Food Safety

16-4-2018

Sebivo (Novartis Europharm Limited)

Sebivo (Novartis Europharm Limited)

Sebivo (Active substance: telbivudine) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2317 of Mon, 16 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/713/T/50

Europe -DG Health and Food Safety

16-4-2018

Farydak (Novartis Europharm Limited)

Farydak (Novartis Europharm Limited)

Farydak (Active substance: panobinostat) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2322 of Mon, 16 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/3725/T/11

Europe -DG Health and Food Safety

16-4-2018

Extavia (Novartis Europharm Limited)

Extavia (Novartis Europharm Limited)

Extavia (Active substance: Interferon beta-1b) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2321 of Mon, 16 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/933/T/90

Europe -DG Health and Food Safety

16-4-2018

Galafold (Amicus Therapeutics UK Ltd)

Galafold (Amicus Therapeutics UK Ltd)

Galafold (Active substance: migalastat) - Centralised - Yearly update - Commission Decision (2018)2318 of Mon, 16 Apr 2018

Europe -DG Health and Food Safety

16-4-2018

Actraphane (Novo Nordisk A/S)

Actraphane (Novo Nordisk A/S)

Actraphane (Active substance: Insulin human (rDNA)) - Centralised - Yearly update - Commission Decision (2018)2312 of Mon, 16 Apr 2018

Europe -DG Health and Food Safety

16-4-2018

Pemetrexed Lilly (Eli Lilly Nederland B.V.)

Pemetrexed Lilly (Eli Lilly Nederland B.V.)

Pemetrexed Lilly (Active substance: pemetrexed) - Centralised - Yearly update - Commission Decision (2018)2308 of Mon, 16 Apr 2018

Europe -DG Health and Food Safety

16-4-2018

Sylvant (Janssen-Cilag International NV)

Sylvant (Janssen-Cilag International NV)

Sylvant (Active substance: siltuximab) - Centralised - Yearly update - Commission Decision (2018)2311 of Mon, 16 Apr 2018

Europe -DG Health and Food Safety

16-4-2018

Fiasp (Novo Nordisk A/S)

Fiasp (Novo Nordisk A/S)

Fiasp (Active substance: insulin aspart) - Centralised - 2-Monthly update - Commission Decision (2018)2309 of Mon, 16 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4046/II/3/G

Europe -DG Health and Food Safety

13-4-2018

Zulvac 8 Ovis (Zoetis Belgium S.A.)

Zulvac 8 Ovis (Zoetis Belgium S.A.)

Zulvac 8 Ovis (Active substance: Inactivated bluetongue virus, serotype 8, strain BTV-8/BEL2006/02 RP* = 1) - Centralised - Yearly update - Commission Decision (2018)2244 of Fri, 13 Apr 2018

Europe -DG Health and Food Safety

10-4-2018

Kineret (Swedish Orphan Biovitrum AB (publ))

Kineret (Swedish Orphan Biovitrum AB (publ))

Kineret (Active substance: Anakinra) - Centralised - 2-Monthly update - Commission Decision (2018)2188 of Tue, 10 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/363/II/56

Europe -DG Health and Food Safety

10-4-2018

Tamiflu (Roche Registration GmbH)

Tamiflu (Roche Registration GmbH)

Tamiflu (Active substance: Oseltamivir) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2185 of Tue, 10 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/402/T/131

Europe -DG Health and Food Safety

10-4-2018

Zelboraf (Roche Registration GmbH)

Zelboraf (Roche Registration GmbH)

Zelboraf (Active substance: vemurafenib) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2184 of Tue, 10 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2409/T/47

Europe -DG Health and Food Safety

10-4-2018

Stronghold Plus (Zoetis Belgium S.A.)

Stronghold Plus (Zoetis Belgium S.A.)

Stronghold Plus (Active substance: selamectin / sarolaner) - Centralised - Yearly update - Commission Decision (2018)2164 of Tue, 10 Apr 2018

Europe -DG Health and Food Safety

10-4-2018

Tarceva (Roche Registration GmbH)

Tarceva (Roche Registration GmbH)

Tarceva (Active substance: Erlotinib) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2186 of Tue, 10 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/618/T/57

Europe -DG Health and Food Safety

10-4-2018

Apoquel (Zoetis Belgium S.A.)

Apoquel (Zoetis Belgium S.A.)

Apoquel (Active substance: Oclacitinib maleate) - Centralised - Yearly update - Commission Decision (2018)2165 of Tue, 10 Apr 2018

Europe -DG Health and Food Safety

10-4-2018

Fuzeon (Roche Registration GmbH)

Fuzeon (Roche Registration GmbH)

Fuzeon (Active substance: Enfuvirtide) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2181 of Tue, 10 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/514/T/50

Europe -DG Health and Food Safety

10-4-2018

Herceptin (Roche Registration GmbH)

Herceptin (Roche Registration GmbH)

Herceptin (Active substance: trastuzumab) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2180 of Tue, 10 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/278/T/142

Europe -DG Health and Food Safety

10-4-2018

RoActemra (Roche Registration GmbH)

RoActemra (Roche Registration GmbH)

RoActemra (Active substance: tocilizumab) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2179 of Tue, 10 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/955/T/75

Europe -DG Health and Food Safety

10-4-2018

Gazyvaro (Roche Registration GmbH)

Gazyvaro (Roche Registration GmbH)

Gazyvaro (Active substance: obinutuzumab) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2178 of Tue, 10 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2799/T/24

Europe -DG Health and Food Safety

10-4-2018

Revolade (Novartis Europharm Limited)

Revolade (Novartis Europharm Limited)

Revolade (Active substance: Eltrombopag) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2182 of Tue, 10 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/1110/T/47

Europe -DG Health and Food Safety

6-4-2018

Bonviva (Atnahs Pharma UK Limited)

Bonviva (Atnahs Pharma UK Limited)

Bonviva (Active substance: Ibandronic acid) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2137 of Fri, 06 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/501/T/64

Europe -DG Health and Food Safety

6-4-2018

Kinzalmono (Bayer AG)

Kinzalmono (Bayer AG)

Kinzalmono (Active substance: telmisartan) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2138 of Fri, 06 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/211/T/111

Europe -DG Health and Food Safety

6-4-2018

Marixino (KRKA, d.d., Novo mesto)

Marixino (KRKA, d.d., Novo mesto)

Marixino (Active substance: Memantine) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2136 of Fri, 06 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2658/T/13

Europe -DG Health and Food Safety

6-4-2018

Convenia (Zoetis Belgium S.A.)

Convenia (Zoetis Belgium S.A.)

Convenia (Active substance: Cefovecin) - Centralised - Yearly update - Commission Decision (2018)2126 of Fri, 06 Apr 2018

Europe -DG Health and Food Safety

6-4-2018

Zulvac 1 Bovis (Zoetis Belgium S.A.)

Zulvac 1 Bovis (Zoetis Belgium S.A.)

Zulvac 1 Bovis (Active substance: Inactivated Bluetongue Virus, serotype 1, strain BTV-1/ALG2006/01 E1 RP = 1) - Centralised - Yearly update - Commission Decision (2018)2127 of Fri, 06 Apr 2018

Europe -DG Health and Food Safety

6-4-2018

Zulvac 1 Ovis (Zoetis Belgium S.A.)

Zulvac 1 Ovis (Zoetis Belgium S.A.)

Zulvac 1 Ovis (Active substance: Inactivated Bluetongue Virus, serotype 1, strain BTV-1/ALG2006/01 E1 RP = 1) - Centralised - Yearly update - Commission Decision (2018)2128 of Fri, 06 Apr 2018

Europe -DG Health and Food Safety

6-4-2018

Zulvac 8 Bovis (Zoetis Belgium S.A.)

Zulvac 8 Bovis (Zoetis Belgium S.A.)

Zulvac 8 Bovis (Active substance: Inactivated bluetongue virus, serotype 8, strain BTV-8/BEL2006/02 RP* = 1) - Centralised - Yearly update - Commission Decision (2018)2129 of Fri, 06 Apr 2018

Europe -DG Health and Food Safety

6-4-2018

Stronghold (Zoetis Belgium S.A.)

Stronghold (Zoetis Belgium S.A.)

Stronghold (Active substance: Selamectin) - Centralised - Yearly update - Commission Decision (2018)2125 of Fri, 06 Apr 2018

Europe -DG Health and Food Safety

6-4-2018

Bondronat (Atnahs Pharma UK Limited)

Bondronat (Atnahs Pharma UK Limited)

Bondronat (Active substance: Ibandronic acid) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)2135 of Fri, 06 Apr 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/101/T/79

Europe -DG Health and Food Safety